ACS Chemical Biology (24) Heﬀron, J. D., Orsburn, B., and Popham, D. L. (2009) Roles of germination-speciﬁc lytic enzymes CwlJ and SleB in Bacillus anthracis. J. Bacteriol. 191, 2237–2247. (25) Heﬀron, J. D., Lambert, E. A., Sherry, N., and Popham, D. L. (2010) Contributions of four cortex lytic enzymes to germination of Bacillus anthracis spores. J. Bacteriol. 192, 763–770. (26) Breukink, E., Wiedemann, I., van Kraaij, C., Kuipers, O. P., Sahl, H., and de Kruijﬀ, B. (1999) Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic. Science 286, 2361–2364. (27) Athamna, A., Athamna, M., Abu-Rashed, N., Medlej, B., Bast, D. J., and Rubinstein, E. (2004) Selection of Bacillus anthracis isolates resistant to antibiotics. J. Antimicrob. Chemother. 54, 424–428. (28) Athamna, A., Massalha, M., Athamna, M., Nura, A., Medlej, B., Ofek, I., Bast, D., and Rubinstein, E. (2004) In vitro susceptibility of Bacillus anthracis to various antibacterial agents and their time-kill activity. J. Antimicrob. Chemother. 53, 247–251. (29) Turnbull, P. C., Sirianni, N. M., LeBron, C. I., Samaan, M. N., Sutton, F. N., Reyes, A. E., and Peruski, L. F., Jr. (2004) MICs of selected antibiotics for Bacillus anthracis, Bacillus cereus, Bacillus thuringiensis, and Bacillus mycoides from a range of clinical and environmental sources as determined by the Etest. J Clin Microbiol 42, 3626–3634. (30) Shi, Y., Yang, X., Garg, N., and van der Donk, W. A. (2010) Production of lantipeptides in Escherichia coli. J. Am. Chem. Soc. 133, 2338–2341. (31) Sheldrick, G. M., Jones, P. G., Kennard, O., Williams, D. H., and Smith, G. A. (1978) Structure of vancomycin and its complex with acetyl-D-alanyl-D-alanine. Nature 271, 223–225. (32) Molinari, H., Pastore, A., Lian, L. Y., Hawkes, G. E., and Sales, K. (1990) Structure of vancomycin and a vancomycin/D-Ala-D-Ala com- plex in solution. Biochemistry 29, 2271–2277. (33) Hsu, S. T., Breukink, E., Tischenko, E., Lutters, M. A., de Kruijﬀ, B., Kaptein, R., Bonvin, A. M., and van Nuland, N. A. (2004) The nisin- lipid II complex reveals a pyrophosphate cage that provides a blueprint for novel antibiotics. Nat. Struct. Mol. Biol. 11, 963–967. (34) Daniel, R. A., and Errington, J. (2003) Control of cell morpho- genesis in bacteria: two distinct ways to make a rod-shaped cell. Cell 113, 767–776. (35) Parsonage, D., Newton, G. L., Holder, R. C., Wallace, B. D., Paige, C., Hamilton, C. J., Dos Santos, P. C., Redinbo, M. R., Reid, S. D., and Claiborne, A. (2010) Characterization of the N-acetyl-R-D-gluco- saminyl l-malate synthase and deacetylase functions for bacillithiol biosynthesis in Bacillus anthracis. Biochemistry 49, 8398–8414. (36) Kedar, G. C., Brown-Driver, V., Reyes, D. R., Hilgers, M. T., Stidham, M. A., Shaw, K. J., Finn, J., and Haselbeck, R. J. (2008) Comparison of the essential cellular functions of the two murA genes of Bacillus anthracis. Antimicrob. Agents Chemother. 52, 2009–2013. (37) Bernard, R., El Ghachi, M., Mengin-Lecreulx, D., Chippaux, M., and Denizot, F. (2005) BcrC from Bacillus subtilis acts as an undeca- prenyl pyrophosphate phosphatase in bacitracin resistance. J. Biol. Chem. 280, 28852–28857. (38) Rink, R., Wierenga, J., Kuipers, A., Kluskens, L. D., Driessen, A. J., Kuipers, O. P., and Moll, G. N. (2007) Dissection and modulation of the four distinct activities of nisin by mutagenesis of rings A and B and by C-terminal truncation. Appl. Environ. Microbiol. 73, 5809–5816. (39) Field, D., Connor, P. M., Cotter, P. D., Hill, C., and Ross, R. P. (2008) The generation of nisin variants with enhanced activity against speciﬁc Gram-positive pathogens. Mol. Microbiol. 69, 218–230. (40) Liu, W., and Hansen, J. N. (1992) Enhancement of the chemical and antimicrobial properties of subtilin by site-directed mutagenesis. J. Biol. Chem. 267, 25078–25085. (41) Parisot, J., Carey, S., Breukink, E., Chan, W. C., Narbad, A., and Bonev, B. (2008) Molecular mechanism of target recognition by subtilin, a class I lanthionine antibiotic. Antimicrob. Agents Chemother. 52, 612–618. (42) Brotz, H., Josten, M., Wiedemann, I., Schneider, U., Gotz, F., Bierbaum, G., and Sahl, H. G. (1998) Role of lipid-bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics. Mol. Microbiol. 30, 317–327. ARTICLES (43) Oman, T. J., and van der Donk, W. A. (2009) Insights into the mode of action of the two-peptide lantibiotic haloduracin. ACS Chem Biol 4, 865–874. (44) Martin, S. W., Tierney, B. C., Aranas, A., Rosenstein, N. E., Franzke, L. H., Apicella, L., Marano, N., and McNeil, M. M. (2005) An overview of adverse events reported by participants in CDC’s anthrax vaccine and antimicrobial availability program. Pharmacoepidemiol. Drug Saf. 14, 393–401. (45) Shepard, C. W., Soriano-Gabarro, M., Zell, E. R., Hayslett, J., Lukacs, S., Goldstein, S., Factor, S., Jones, J., Ridzon, R., Williams, I., and Rosenstein, N. (2002) Antimicrobial postexposure prophylaxis for anthrax: adverse events and adherence. Emerging Infect. Dis. 8, 1124–1132. 752 dx.doi.org/10.1021/cb1004178 |ACS Chem. Biol. 2011, 6, 744–752